'I couldn't put down this thriller . . . a book so compelling that I couldn't turn away' - Bill Gates
'A story so incredible you'd think it was fiction' - James Patterson
Winner of the Financial Times/McKinsey Business Book of the Year Award.
The shocking true story of the breathtaking rise and collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, written by the prize-winning journalist who first broke the story and pursued it to the end.
Seen as the female Steve Jobs, Theranos founder and CEO Elizabeth Holmes was a brilliant Stanford dropout whose startup 'unicorn' promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by wealthy investors, Theranos sold shares that valued the company at more than $9 billion.
There was just one problem: the technology didn't work . . .
Despite threats of legal action, brave whistleblowers started to talk. They revealed a culture of intimidation and secrecy, technology that repeatedly failed, results sent to real patients that were incorrect but upon which life-changing medical decisions were being made, with devastating consequences.
The riveting story behind The Dropout, in Bad Blood, John Carreyrou investigates the biggest corporate fraud since Enron, a tale of ambition and scandal set amid the bold promises of Silicon Valley.
'A tale of corporate fraud and legal browbeating that reads like a crime thriller' - TIME, The 10 Best Nonfiction Books of the Year
ISBN: | 9781035006779 |
Publication date: | 30th March 2023 |
Author: | John Carreyrou |
Publisher: | Picador an imprint of Pan Macmillan |
Format: | Paperback |
Pagination: | 400 pages |
Genres: |
True crime Biography: business and industry Corporate crime / white-collar crime Business ethics and social responsibility Biotechnology Reportage, journalism or collected columns |